AU2002365941A1 - Methods of diagnosis, monitoring and treatment of fertility - Google Patents

Methods of diagnosis, monitoring and treatment of fertility

Info

Publication number
AU2002365941A1
AU2002365941A1 AU2002365941A AU2002365941A AU2002365941A1 AU 2002365941 A1 AU2002365941 A1 AU 2002365941A1 AU 2002365941 A AU2002365941 A AU 2002365941A AU 2002365941 A AU2002365941 A AU 2002365941A AU 2002365941 A1 AU2002365941 A1 AU 2002365941A1
Authority
AU
Australia
Prior art keywords
fertility
diagnosis
monitoring
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002365941A
Other versions
AU2002365941A8 (en
Inventor
Yousef Ai-Abed
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
North Shore Long Island Jewish Research Institute
Original Assignee
North Shore Long Island Jewish Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by North Shore Long Island Jewish Research Institute filed Critical North Shore Long Island Jewish Research Institute
Publication of AU2002365941A1 publication Critical patent/AU2002365941A1/en
Publication of AU2002365941A8 publication Critical patent/AU2002365941A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/533—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving isomerase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2002365941A 2001-12-05 2002-12-05 Methods of diagnosis, monitoring and treatment of fertility Abandoned AU2002365941A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35575501P 2001-12-05 2001-12-05
US60/355,755 2001-12-05
PCT/US2002/038629 WO2003065979A2 (en) 2001-12-05 2002-12-05 Methods of diagnosis, monitoring and treatment of fertility

Publications (2)

Publication Number Publication Date
AU2002365941A1 true AU2002365941A1 (en) 2003-09-02
AU2002365941A8 AU2002365941A8 (en) 2003-09-02

Family

ID=27734557

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002365941A Abandoned AU2002365941A1 (en) 2001-12-05 2002-12-05 Methods of diagnosis, monitoring and treatment of fertility

Country Status (2)

Country Link
AU (1) AU2002365941A1 (en)
WO (1) WO2003065979A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140679A (en) 2001-05-24 2010-01-15 Avanir Pharmaceuticals Inhibitors of macrohage migration inhibitory factor and methods for identifying the same
TW200418829A (en) 2003-02-14 2004-10-01 Avanir Pharmaceutics Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
WO2006102191A1 (en) 2005-03-24 2006-09-28 Avanir Pharmaceuticals Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors
WO2007044622A1 (en) * 2005-10-07 2007-04-19 Yale University Use of mif and mif pathway agonists
EP2443920B1 (en) * 2009-06-17 2016-12-21 Hiroshima University Sperm diluent solution and method for artificial insemination using same
US20150359763A1 (en) * 2013-01-30 2015-12-17 Board Of Regents Of The Nevada System Of Higher Education, On Behalf Of The University Of Nevada Use of 3-bromopyruvate as a contraceptive

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6492428B1 (en) * 2000-07-26 2002-12-10 The Picower Institute For Medical Research Compounds having MIF antagonist activity
US6420188B1 (en) * 1996-02-16 2002-07-16 The Picower Institute For Medical Research Screening assay for the identification of inhibitors for macrophage migration inhibitory factor

Also Published As

Publication number Publication date
WO2003065979A2 (en) 2003-08-14
WO2003065979A3 (en) 2004-02-12
AU2002365941A8 (en) 2003-09-02

Similar Documents

Publication Publication Date Title
AUPR733901A0 (en) Method and means of physiological monitoring
WO2002086502A8 (en) Methods for the diagnosis and treatment of bone disorders
AU2002255248A1 (en) Diagnosis, treatment and research of mental disorders
AU2002341361A1 (en) Device, system, and method for cryosurgical treatment of cardiac arrhythmia
EP1374935A4 (en) Medical syringe, and method of producing the same
AU2002243549A1 (en) Diagnostic and monitoring methods for cancer
AU2002247004A1 (en) Methods of diagnosis and treatment of osteoporosis
AU2002345653A1 (en) Diagnostic device, system and method
AU2002346783A1 (en) Composite nonwoven, its use and method of manufacture
AU2002329570A1 (en) Method of monitoring neuroprotective treatment
AU6630101A (en) Chest piece for stethoscopes, and methods of utilizing stethoscopes for monitoring the physiological conditons of patient
AU2002348297A1 (en) Proteonomic methods for diagnosis and monitoring of breast cancer
AU2002321349A1 (en) Method for modification of starch, starch and its use
AU2002312315A1 (en) Microfabricated surgical devices and methods of making the same
AU2002219137A1 (en) Diagnosis kit, dna chip, and methods for diagnosing or supervising the treatment of testicular cancer
AU2002324072A1 (en) Method, device and system for measuring and transmitting functional values of the body
AU2001236234A1 (en) Patient monitoring devices and methods
AU2002365941A1 (en) Methods of diagnosis, monitoring and treatment of fertility
AU2002330724A1 (en) Diagnosis, prevention and treatment of cancer
AU2002246049A1 (en) Water-absorbing agent, method for the production thereof and use of the same
AU4654500A (en) Prevention, diagnosis and treatment of lyme disease
AU2001277737A1 (en) Novel substance having physiological activity, process for producing the same, and use
AU2002249891A1 (en) Compounds and methods for the diagnosis and treatment of babesia infection
AU2002240745A1 (en) Diagnosis and treatment of blood disorders
AU2002100671A4 (en) Method and means of physiological monitoring

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase